tiprankstipranks
Trending News
More News >
Nuvation Bio (NUVB)
NYSE:NUVB
US Market

Nuvation Bio (NUVB) Income Statement

Compare
684 Followers

Nuvation Bio Income Statement

Last quarter (Q3 2025), Nuvation Bio's total revenue was $13.12M, an increase of 1704.68% from the same quarter last year. In Q3, Nuvation Bio's net income was $-55.79M. See Nuvation Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 7.87M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 795.00K$ 0.00$ 0.00$ 0.00$ -103.00K
Operating Expenses
$ 593.42M$ 99.82M$ 119.73M$ 93.32M$ 43.45M
Depreciation and Amortization
$ 683.00K$ 222.00K$ 199.00K$ 184.00K$ 103.00K
EBITDA
$ -566.91M$ -75.58M$ -119.53M$ -93.13M$ -41.56M
Operating Income
$ -592.63M$ -99.82M$ -119.73M$ -93.32M$ -43.55M
Other Income/Expenses
$ 24.69M$ 24.02M$ 15.54M$ 6.47M$ 1.89M
Pretax Income
$ -567.94M$ -75.80M$ -104.20M$ -86.85M$ -41.66M
Net Income
$ -567.94M$ -75.80M$ -104.20M$ -86.85M$ -41.66M
Per Share Metrics
Basic EPS
$ -2.11$ -0.35$ -0.48$ -0.44$ -0.19
Diluted EPS
$ -2.11$ -0.35$ -0.48$ -0.44$ -0.19
Weighted Average Shares Outstanding
268.77M 218.88M 216.72M 197.89M 217.65M
Weighted Average Shares Outstanding (Diluted)
268.77M 218.88M 216.72M 197.89M 217.65M
Currency in USD

Nuvation Bio Earnings and Revenue History